Skip to main content

Table 1 Demographic characteristics of enrolled patients

From: Premedication with reformulated simethicone and sodium bicarbonate improves mucosal visibility during upper gastrointestinal endoscopy: a double-blind, multicenter, randomized controlled trial

 

Group A (n = 354)

Group B (n = 169)

P value

Age, mean ± SD (years)

48.5 ± 13.2

47.5 ± 12.7

0.487

Sex, n

  

1.000

 Male

201

96

 

 Female

153

73

 

Indication

  

0.338

 No obvious symptom

68

37

 

 Screening

64

33

 

 H. plori infection

3

4

 

 Increased serum tumor marker

1

0

 

 Acid regurgitation

22

6

 

 Dyspepsia

182

79

 

 Abdominal pain or discomfort

62

40

 

 Vomit

1

0

 

 Constipation

0

1

 

 Dysphagia

1

0

 

 Gastrointestinal bleeding

10

4

 

 Distention

8

2